Recently, Zhejiang Qilin Zhengwei Medical Technology Co., Ltd., a new hydrogen molecule anti-aging material company, announced the completion of Series A financing of tens of millions of yuan, led by Tiantu Investment's Beautiful Pilot Fund. This round of financing will focus on core technology iteration, Huzhou production base construction, market system expansion and core team building to continue to consolidate the company's leading position in the hydrogen molecular transdermal anti-aging new materials circuit, and comprehensively accelerate the industrialization process of hydrogen medical materials in various consumption scenarios such as beauty, health care, and medical dressings.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.